Chronic liver disease is not inevitably a progressive disease.

被引：0
作者：
Zgheib, N. K. [1 ]
Buch, S. [1 ]
Steele, A. [1 ]
Shaw-Stiffel, T. A. [1 ]
Zacharia, L. [1 ]
Romkes, M. [1 ]
Branch, R. A. [1 ]
机构：
[1] Univ Michigan, Med Ctr, Pittsburgh, PA USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2007年 / 81卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S75 / S75
页数：1
相关论文
共 50 条
  • [31] Pathophysiological and clinical role of erythropoietin in chronic liver disease.
    Tacke, F
    Schöffski, P
    Ganser, A
    Manns, MP
    Trautwein, C
    HEPATOLOGY, 2002, 36 (04) : 515A - 515A
  • [32] Serum thrombopoietin and hepatosplenomegaly in patients with chronic liver disease.
    Satoi, J
    Sanjyou, Y
    Takekuma, A
    Nekohashi, T
    Abe, T
    Tsuboi, Y
    Suzuki, N
    Kato, T
    Tahara, T
    Tanaka, T
    HEPATOLOGY, 1997, 26 (04) : 309 - 309
  • [33] New markers of oxidant stress in chronic liver disease.
    Pemberton, P
    Jain, S
    Smith, A
    Warnes, TW
    GASTROENTEROLOGY, 1998, 114 (04) : A1321 - A1321
  • [34] Adrenal dysfunction is associated with acute and chronic liver disease.
    Harry, R
    Auzinger, G
    Wendon, J
    HEPATOLOGY, 2001, 34 (04) : 194A - 194A
  • [35] Global DNA hypermethylation in chronic lymphocytic leukemia correlates with progressive disease.
    Yu, MK
    Szabo, A
    Bergonia, H
    Senina, A
    Phillips, JD
    BLOOD, 2005, 106 (11) : 333B - 333B
  • [36] Interviewing for chronic disease.
    Scheewe, S.
    ALLERGOLOGIE, 2010, 33 (10) : 469 - 469
  • [37] Prognosis in chronic disease.
    不详
    LANCET, 1925, 1 : 288 - 288
  • [38] HYDROTHERAPY IN CHRONIC DISEASE.
    Baruch, Simon
    BOSTON MEDICAL AND SURGICAL JOURNAL, 1901, 145 (14): : 8 - 13
  • [39] Reproducibility of alcohol consumption histories in patients with chronic liver disease.
    Herrine, S
    Greenberg, A
    Moretti, D
    Fenkel, J
    Campbell, K
    Davis, GW
    Oh, M
    Swaminathan, M
    Navarro, V
    HEPATOLOGY, 2003, 38 (04) : 672A - 672A
  • [40] Possible link between chronic hypercholesterolemia and fibrotic liver disease.
    Gidwani, P
    Miller, A
    King, K
    Thompson, K
    Asher, J
    Xu, HZ
    Coger, R
    Clemens, MG
    Zhang, JX
    FASEB JOURNAL, 2002, 16 (04) : A456 - A456
12345